Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of June 2026
Rose Prince @Rose Prince
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative technical analysis

Market capitalization:

$8,149,975talents

Virtual portfolio value:

$5,071,817talents

Net overall return per annum:

18.70%

AYA current rank order:

#14

Asset investment philosophy:
Rose Prince trades U.S. stocks with the top #201 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
VATE INNOVATE Corp. Common Stock $0.53 $4.14 91,603 +681.13% $330,687
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 12,852 +2,108.33% $97,547
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 3,340 +660.87% $76,152
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,665 +589.24% $68,382
TUEM Tuesday Morning Corp. Common Stock $0.12 $0.69 103,558 +475.00% $59,028
NTZ Natuzzi S.p.A. $2.21 $11.92 5,254 +439.37% $51,016
GNRC Generac Holdlings Inc. Common Stock $42.64 $219.38 272 +414.49% $48,073
CDNS Cadence Design Systems Inc. Common Stock $29.82 $150.85 389 +405.87% $47,081
MPWR Monolithic Power Systems Inc. Common Stock $85.91 $392.24 135 +356.57% $41,355
BBX BBX Capital Corporation $2.54 $14.54 2,191 +472.44% $26,292
Sum $845,613

Top 10 current stock portfolio positions as of June 2026Strategy

Symbol Company Price Position Capitalization
QURE uniQure N.V. Ordinary Shares $46.29 757 $35,041
NVCT Nuvectis Pharma Inc. Common Stock $13.82 2,217 $30,638
AMAT Applied Materials Inc. Common Stock $617.11 48 $29,621
MBX MBX Biosciences Inc. Common Stock $43.03 686 $29,518
HIMS Hims & Hers Health Inc. Class A Common Stock $35.47 826 $29,298
COHU Cohu Inc. Common Stock $69.40 409 $28,384
MAMA Mama's Creations Inc. Common Stock $17.77 1,566 $27,827
ENTG Entegris Inc. Common Stock $178.77 155 $27,709
HURC Hurco Companies Inc. Common Stock $22.00 1,259 $27,698
ACMR ACM Research Inc. Class A Common Stock $109.87 249 $27,357
Sum $293,091

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@Andy Yeh Alpha

Blog+More

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of IBM (International Business Machines) (U.S. stock symbol: $IBM).

Laura Hermes

2025-10-11 14:33:00 Saturday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of IBM (International Business Machines) (U.S. stock symbol: $IBM).

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund

+See More

Smart firms and customers connect the continuous flow of lean production to the lean consumption of cost-effective minimum viable products.

Olivia London

2020-07-26 15:29:00 Sunday ET

Smart firms and customers connect the continuous flow of lean production to the lean consumption of cost-effective minimum viable products.

Firms and customers create value and wealth together by joining the continual flow of small batches of lean production to the lean consumption of cost-effec

+See More

With majority control, House Democrats pass 2 bills to reopen the U.S. government without funding the Trump border wall.

John Fourier

2019-01-12 10:33:00 Saturday ET

With majority control, House Democrats pass 2 bills to reopen the U.S. government without funding the Trump border wall.

With majority control, House Democrats pass 2 bills to reopen the U.S. government without funding the Trump border wall. President Trump makes a surprise Wh

+See More

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

John Fourier

2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its

+See More

U.S. inflation has become sustainably less than the 2% policy target in recent years.

Jonah Whanau

2019-08-03 09:28:00 Saturday ET

U.S. inflation has become sustainably less than the 2% policy target in recent years.

U.S. inflation has become sustainably less than the 2% policy target in recent years. As Harvard macro economist Robert Barro indicates, U.S. inflation has

+See More

The U.S. further derisks and decouples from China.

Peter Prince

2023-05-31 03:15:40 Wednesday ET

The U.S. further derisks and decouples from China.

The U.S. further derisks and decouples from China.   Why does the U.S. seek to further economically decouple from China? In recent times, th

+See More